Results 41 to 50 of about 101,810 (380)
This study aimed to design an effective nanoparticle-based carrier for the oral delivery of fisetin (FST) with improved biopharmaceutical properties. FST-loaded nanoparticles were prepared with polyvinyl alcohol (PVA) and poly(lactic-co-glycolic acid ...
Wan-Yi Liu +3 more
semanticscholar +1 more source
Introduction: The biomedical industry has grown significantly both globally and in China; however, there are still challenges. This study aimed at evaluating the biopharmaceutical sector of China, in terms of ability to innovate, current sales volume ...
Ruomeng Yang +25 more
doaj +1 more source
Monoclonal antibodies have been established as the largest product class of biopharmaceuticals. Since extensive characterization is required for development and quality control of monoclonal antibody, a widely available reference material (RM) is needed.
Tomoya Kinumi +9 more
doaj +1 more source
As competition in the biopharmaceutical market gets keener due to the market entry of biosimilars, process analytical technologies (PATs) play an important role for process automation and cost reduction.
Laura Rolinger +2 more
semanticscholar +1 more source
Enhancing research and development and ensuring equitable pricing and access to cutting-edge treatments are both vital to a biopharmaceutical innovation system that works in the public interest.
M. Mazzucato, Henry Lishi Li
semanticscholar +1 more source
Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production [PDF]
Many high-value added recombinant proteins, such as therapeutic glycoproteins, are produced using mammalian cell cultures. In order to optimise the productivity of these cultures it is important to monitor cellular metabolism, for example the utilisation
Ainsworth, C +5 more
core +1 more source
Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review [PDF]
Kevin Buckley, Alan G. Ryder
openalex +2 more sources
Developments and opportunities in continuous biopharmaceutical manufacturing
Today’s biologics manufacturing practices incur high costs to the drug makers, which can contribute to high prices for patients. Timely investment in the development and implementation of continuous biomanufacturing can increase the production of ...
Ohnmar Khanal, A. Lenhoff
semanticscholar +1 more source
Control strategy for biopharmaceutical production by model predictive control
The biopharmaceutical industry is rapidly advancing, driven by the need for cutting‐edge technologies to meet the growing demand for life‐saving treatments.
T. Eslami, Alois Jungbauer
semanticscholar +1 more source
End‐to‐end collaboration to transform biopharmaceutical development and manufacturing
An ambitious 10‐year collaborative program is described to invent, design, demonstrate, and support commercialization of integrated biopharmaceutical manufacturing technology intended to transform the industry.
J. Erickson +23 more
semanticscholar +1 more source

